WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

The future of children’s vaccines is on the agenda at today’s meeting of federal vaccine advisers, who are reviewing the ...

AI use has exploded in radiology as the field struggles with staffing shortages, exacerbated by growing imaging volumes.

Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through ...

In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.

The complexity of developing and manufacturing, coupled with market and regulatory dynamics, has put biosimilars out of reach ...

We ask why so many Black and immigrant women avoid prenatal care. We should ask why they'd trust a system that often doesn’t ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

The FDA plans to begin requiring one clinical study, instead of the standard two, for medical products before consideration ...